398 related articles for article (PubMed ID: 20410271)
1. Establishment of HIV latency in primary CD4+ cells is due to epigenetic transcriptional silencing and P-TEFb restriction.
Tyagi M; Pearson RJ; Karn J
J Virol; 2010 Jul; 84(13):6425-37. PubMed ID: 20410271
[TBL] [Abstract][Full Text] [Related]
2. T-cell receptor signaling enhances transcriptional elongation from latent HIV proviruses by activating P-TEFb through an ERK-dependent pathway.
Kim YK; Mbonye U; Hokello J; Karn J
J Mol Biol; 2011 Jul; 410(5):896-916. PubMed ID: 21763495
[TBL] [Abstract][Full Text] [Related]
3. Efficient Non-Epigenetic Activation of HIV Latency through the T-Cell Receptor Signalosome.
Hokello J; Sharma AL; Tyagi M
Viruses; 2020 Aug; 12(8):. PubMed ID: 32784426
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency.
Pearson R; Kim YK; Hokello J; Lassen K; Friedman J; Tyagi M; Karn J
J Virol; 2008 Dec; 82(24):12291-303. PubMed ID: 18829756
[TBL] [Abstract][Full Text] [Related]
5. Biogenesis of P-TEFb in CD4+ T cells to reverse HIV latency is mediated by protein kinase C (PKC)-independent signaling pathways.
Mbonye U; Leskov K; Shukla M; Valadkhan S; Karn J
PLoS Pathog; 2021 Sep; 17(9):e1009581. PubMed ID: 34529720
[TBL] [Abstract][Full Text] [Related]
6. An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression.
Darcis G; Kula A; Bouchat S; Fujinaga K; Corazza F; Ait-Ammar A; Delacourt N; Melard A; Kabeya K; Vanhulle C; Van Driessche B; Gatot JS; Cherrier T; Pianowski LF; Gama L; Schwartz C; Vila J; Burny A; Clumeck N; Moutschen M; De Wit S; Peterlin BM; Rouzioux C; Rohr O; Van Lint C
PLoS Pathog; 2015 Jul; 11(7):e1005063. PubMed ID: 26225566
[TBL] [Abstract][Full Text] [Related]
7. Short Communication: The Broad-Spectrum Histone Deacetylase Inhibitors Vorinostat and Panobinostat Activate Latent HIV in CD4(+) T Cells In Part Through Phosphorylation of the T-Loop of the CDK9 Subunit of P-TEFb.
Jamaluddin MS; Hu PW; Jan Y; Siwak EB; Rice AP
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):169-73. PubMed ID: 26727990
[TBL] [Abstract][Full Text] [Related]
8. Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.
Li C; Wang HB; Kuang WD; Ren XX; Song ST; Zhu HZ; Li Q; Xu LR; Guo HJ; Wu L; Wang JH
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795436
[TBL] [Abstract][Full Text] [Related]
9. FACT Proteins, SUPT16H and SSRP1, Are Transcriptional Suppressors of HIV-1 and HTLV-1 That Facilitate Viral Latency.
Huang H; Santoso N; Power D; Simpson S; Dieringer M; Miao H; Gurova K; Giam CZ; Elledge SJ; Zhu J
J Biol Chem; 2015 Nov; 290(45):27297-27310. PubMed ID: 26378236
[TBL] [Abstract][Full Text] [Related]
10. The KAT5-Acetyl-Histone4-Brd4 axis silences HIV-1 transcription and promotes viral latency.
Li Z; Mbonye U; Feng Z; Wang X; Gao X; Karn J; Zhou Q
PLoS Pathog; 2018 Apr; 14(4):e1007012. PubMed ID: 29684085
[TBL] [Abstract][Full Text] [Related]
11. The Molecular Basis for Human Immunodeficiency Virus Latency.
Mbonye U; Karn J
Annu Rev Virol; 2017 Sep; 4(1):261-285. PubMed ID: 28715973
[TBL] [Abstract][Full Text] [Related]
12. CBF-1 promotes transcriptional silencing during the establishment of HIV-1 latency.
Tyagi M; Karn J
EMBO J; 2007 Dec; 26(24):4985-95. PubMed ID: 18007589
[TBL] [Abstract][Full Text] [Related]
13. The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and Reversed.
Rezaei SD; Lu HK; Chang JJ; Rhodes A; Lewin SR; Cameron PU
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643247
[TBL] [Abstract][Full Text] [Related]
14. Prostratin antagonizes HIV latency by activating NF-kappaB.
Williams SA; Chen LF; Kwon H; Fenard D; Bisgrove D; Verdin E; Greene WC
J Biol Chem; 2004 Oct; 279(40):42008-17. PubMed ID: 15284245
[TBL] [Abstract][Full Text] [Related]
15. A Two-Color Haploid Genetic Screen Identifies Novel Host Factors Involved in HIV-1 Latency.
Röling M; Mollapour Sisakht M; Ne E; Moulos P; Crespo R; Stoszko M; De Crignis E; Bodmer H; Kan TW; Akbarzadeh M; Harokopos V; Hatzis P; Palstra RJ; Mahmoudi T
mBio; 2021 Dec; 12(6):e0298021. PubMed ID: 34872356
[TBL] [Abstract][Full Text] [Related]
16. HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κB.
Saleh S; Lu HK; Evans V; Harisson D; Zhou J; Jaworowski A; Sallmann G; Cheong KY; Mota TM; Tennakoon S; Angelovich TA; Anderson J; Harman A; Cunningham A; Gray L; Churchill M; Mak J; Drummer H; Vatakis DN; Lewin SR; Cameron PU
Retrovirology; 2016 Jul; 13(1):49. PubMed ID: 27459960
[TBL] [Abstract][Full Text] [Related]
17. Combinatorial Use of Both Epigenetic and Non-Epigenetic Mechanisms to Efficiently Reactivate HIV Latency.
Hokello J; Sharma AL; Tyagi M
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918134
[TBL] [Abstract][Full Text] [Related]
18. Regulation of cyclin T1 during HIV replication and latency establishment in human memory CD4 T cells.
Couturier J; Orozco AF; Liu H; Budhiraja S; Siwak EB; Nehete PN; Sastry KJ; Rice AP; Lewis DE
Virol J; 2019 Feb; 16(1):22. PubMed ID: 30786885
[TBL] [Abstract][Full Text] [Related]
19. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.
Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST
mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583
[TBL] [Abstract][Full Text] [Related]
20. Alternate NF-κB-Independent Signaling Reactivation of Latent HIV-1 Provirus.
Acchioni C; Remoli AL; Marsili G; Acchioni M; Nardolillo I; Orsatti R; Farcomeni S; Palermo E; Perrotti E; Barreca ML; Sabatini S; Sandini S; Parolin C; Lin R; Borsetti A; Hiscott J; Sgarbanti M
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
